Healthcare -
Biotechnology - NASDAQ - US
$ 1.25
-1.28 %
$ 3.96 M
Market Cap
-0.1
P/E
SONN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities SONN - Sonnet BioTherapeutics Holdings, Inc.
-12 K
LAST VALUE
88.43%
2 YEAR CAGR
65.47%
5 YEAR CAGR
40.54%
10 YEAR CAGR